(Q39950836)

15 September 2017

title

Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide (English)

1 reference

15 September 2017

1 reference

Y T Ko

1

1 reference

15 September 2017

W C Hartner

series ordinal

2

1 reference

15 September 2017

A Kale

series ordinal

3

1 reference

15 September 2017

V P Torchilin

series ordinal

4

1 reference

15 September 2017

language of work or name

1 reference

14 August 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

16

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

52-59

1 reference

Conditionally replicative adenoviral vectors for cancer gene therapy

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Targeting the heart with gene therapy-optimized gene delivery methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Gene therapy in heart and lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Molecular cardiomyoplasty: potential cardiac gene therapy for chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Gene therapy for donor hearts: ex vivo liposome-mediated transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

TAT-liposomes: a novel intracellular drug carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Plug and seal: Prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Monoclonal antibody 2C5-mediated binding of liposomes to brain tumor cells in vitro and in subcutaneous tumor model in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Poly(ethylene glycol)-Modification of the Phospholipid Vesicles by Using the Spontaneous Incorporation of Poly(ethylene glycol)-Lipid into the Vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

Ex vivo transfection of pulmonary artery segments in lung isografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

7 January 2021

Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

7 January 2021

The heat-shock proteins

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

7 January 2021

Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

7 January 2021

Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

7 January 2021

Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

7 January 2021

Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

7 January 2021

Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

7 January 2021

Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

7 January 2021

A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.135

7 January 2021

Identifiers

DOI

10.1038/GT.2008.135

1 reference

15 September 2017

1 reference